Thursday, August 9, 2012

Growing Nodality strikes drug-development deal with Pfizer

Nodality Inc. scored a deal Thursday to help Pfizer Inc., the world's largest drug maker, better develop drugs. The multi-year deal, financial terms for which weren't disclosed, initially will focus on autoimmune diseases, particularly lupus. Plus, Pfizer has an option to use Nodality's technology to develop companion diagnostics.

No comments:

Post a Comment